BBA
ALT icon

Baader Bank Aktiengesellschaft’s Altimmune ALT Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,292
Closed -$82K – 491
2025
Q2 		$82K Buy
+34,292
New +$186K 0.01% 401

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Baader Bank Aktiengesellschaft's ALT Position: Q3 2025 in Review

Baader Bank Aktiengesellschaft sold out of Altimmune (ALT) in Q3 2025, closing a stake of 34,292 shares — an estimated $82K sold.

Baader Bank Aktiengesellschaft first reported a position in ALT in Q2 2025 and held it in 1 quarter. The position peaked at $82K in Q2 2025. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Baader Bank Aktiengesellschaft reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 34,292 Altimmune shares in Q3 2025, an estimated $82K.
  • Baader Bank Aktiengesellschaft first reported a position in Altimmune in Q2 2025 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Altimmune position peaked at $82K in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2025, filed 6 Nov 2025.